NCT00756171View on ClinicalTrials.gov

Colesevelam Versus Placebo in Cholestatic Pruritus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

December 31, 2009

Conditions
Chronic Liver Disease
Interventions
DRUG

colesevelam

2 times 3 625 mg tablets daily, 3 weeks

DRUG

placebo

2 times 3 625mg tablets daily

Trial Locations (3)

Unknown

Amsterdam Medical Center, Amsterdam

Erasmus Medical Center, Rotterdam

University Medical Center Utrecht, Utrecht

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER